NIH-funded research R01 grant

Understanding how intestinal cells use TET3 to control DNA and gene activity

Official title: Mechanism of intestinal TET3-mediated DNA oxidation and transcriptional regulation

Funded at Rutgers the State Univ of Nj Newark · NIH-11377068 · Data updated 2026-11-12

This grant studies how a specific gene (TET3) in gut lining cells changes DNA marks to control which genes are turned on or off, with potential implications for intestinal health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers the State Univ of Nj Newark
NIH-funded
Lab location1 site (Newark, United States)
Project startAugust 15, 2024
Project endJune 30, 2028
Funding year2026
Award (this year)$1,066,174
NIH project number4R01DK139790-03
Project IDNIH-11377068 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include adults with healthy or diseased intestinal tissue or those who could donate samples to study DNA modification and gene regulation in the gut.

Less likely to help

Individuals without access to intestinal tissue samples or those not affected by gut diseases may not directly benefit.

What this research studies

Researchers will examine how TET3 drives DNA oxidation and regulation of gene activity in intestinal epithelial cells, exploring how environmental factors like microbiota and stress influence these processes. The project combines molecular analyses of DNA modifications with experiments in human intestinal tissue or cells to map when and where TET3 acts. The goal is to uncover mechanisms that maintain healthy gut cell function and how disruptions may contribute to disease. Findings could point to new ways to support gut health or prevent bowel diseases.

Why it matters

Potential benefit: A better understanding of TET3’s role could lead to new approaches for maintaining intestinal health and preventing gut disorders.

How similar studies have gone: Previous work has shown that TET enzymes influence DNA methylation dynamics, supporting potential relevance of this approach.

Where this research is happening

  • Rutgers the State Univ of Nj Newark
    Newark, United States
    Active

Researchers

  • Principal investigator: Etchegaray, Jean-Pierre — Rutgers the State Univ of Nj Newark
  • Study coordinator: Etchegaray, Jean-Pierre

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.